Literature DB >> 2353670

Role of magnesium in cardiac tachyarrhythmias.

L T Iseri1.   

Abstract

The efficacy of magnesium therapy in patients with ventricular tachycardia has previously been reported. Recently completed and ongoing studies validate earlier observations that potassium and magnesium supplementation may control other cardiac arrhythmias, particularly in hypomagnesemic patients. Magnesium treatment is a viable therapeutic option when other antiarrhythmic agents fail to suppress ventricular tachycardia, ventricular fibrillation, multifocal atrial tachycardia, atrial fibrillation and supraventricular tachycardia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2353670     DOI: 10.1016/0002-9149(90)91280-j

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  [Medicamentous anti-arrhythmia therapy. Is oral adjuvant therapy with electrolytes of value?].

Authors:  R Haberl
Journal:  Herz       Date:  1997-06       Impact factor: 1.443

2.  Effects of pretreatment with magnesium on muscle relaxation and cardiovascular responses in tracheal intubation using the priming principle for vecuronium.

Authors:  Misuzu Nishiyama; Yuzuru Yanbe
Journal:  J Anesth       Date:  1997-03       Impact factor: 2.078

Review 3.  Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis.

Authors:  James J DiNicolantonio; James H O'Keefe; William Wilson
Journal:  Open Heart       Date:  2018-01-13

4.  Magnesium for the prevention and treatment of cardiovascular disease.

Authors:  James J DiNicolantonio; Jing Liu; James H O'Keefe
Journal:  Open Heart       Date:  2018-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.